AI assistant
Sending…
Sopharma AD — Earnings Release 2023
Jan 22, 2024
2543_rns_2024-01-22_36188bfe-9be6-4ca7-8f4d-bc586f9d0fd0.pdf
Earnings Release
Open in viewerOpens in your device viewer
Current report № 3/ 2024 Dated January 22, 2024
NOTIFICATION
"Sopharma" AD (the Company) notifies that for December 2023 the Company recorded a decrease in sales of 57% compared to the same month of the previous year, incl. 27% decrease in domestic sales and 68% decrease in export sales.
For 2023 the revenues from sales of products increase by 7%, incl. 1% increase of sales for the domestic market and 11% increase in export sales.
Ognian Donev
More from Sopharma AD
Transaction in Own Shares
2026
May 22
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 21
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 19
Transaction in Own Shares
2026
May 18
Transaction in Own Shares
2026
May 15
Transaction in Own Shares
2026
May 14
Transaction in Own Shares
2026
May 13
Transaction in Own Shares
2026
May 12